Hyloris Acquires Breakthrough, Patented Technology to Develop and Market Aspirin IV in the U.S. ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 6 - Van Rompay News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Van Rompay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Van Rompay Today - Breaking & Trending Today
Hyloris Expands Cardiovascular Pipeline with Breakthrough
Patient-friendly alternative to continuous IV administration – proven safety and efficacyTargeting orphan, late-stage heart failure indication with high...
Source: globenewswire.com
Hyloris Expands Cardiovascular Pipeline with Breakthrough Extended-Release Milrinone Capsule in ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Hyloris Announces Further Extension of Maxigesic® IV Footprint
Regulatory approvals in South Korea, the fourth largest pharma market in Asia, and PanamaMaxigesic® IV provides a non-opioid, dual mode-of-action pain management alternative to traditional analgesics ...
Source: teletrader.com
Hyloris Reports 2021 Half-Year Results: Multiple Potential Value Inflection Points Ahead
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Hyloris Reports 2021 Half-Year Results: Multiple Potential Value Inflection Points Ahead Hyloris Pharmaceuticals SAAugust 4, 2021 GMT On target to grow the broad product pipeline with at least 3 additional programmes before end 2021 Significant expansion of commercial footprint of non-opioid pain treatment Maxigesic® IV Expected to start 2 clinical studies and to report the results from 2 clinical studies before year-end €53.47 million in cash and cash equivalents to execute ambitious growth ...
Source: apnews.com